ArticleFrontiers in endocrinology2019

Sema3a as a Novel Therapeutic Option for High Glucose-Suppressed Osteogenic Differentiation in Diabetic Osteopathy.

Lixia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.